- Type / Class
- Equity / Common Stock
- Shares outstanding
- 129,867,819
- Total 13F shares
- 125,764,461
- Share change
- -1,727,699
- Total reported value
- $1,744,349,407
- Put/Call ratio
- 18%
- Price per share
- $13.87
- Number of holders
- 253
- Value change
- -$25,594,791
- Number of buys
- 96
- Number of sells
- 124
Quarterly Holders Quick Answers
What is CUSIP 64049M209?
CUSIP 64049M209 identifies NEO - NEOGENOMICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64049M209:
Top shareholders of NEO - NEOGENOMICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
19,850,864
|
$312,055,585 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
14,211,019
|
$223,397,220 | — | 31 Mar 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
7.4%
|
9,669,775
|
$152,008,865 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
5.3%
|
6,857,581
|
$107,802,000 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.8%
|
6,280,866
|
$98,734,887 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
4,897,766
|
$76,992,882 | — | 31 Mar 2024 | |
| Greenhouse Funds LLLP |
13F
|
Company |
3.4%
|
4,396,354
|
$69,110,685 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.1%
|
4,023,509
|
$63,250,000 | — | 31 Mar 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.5%
|
3,302,165
|
$51,910,034 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
3,106,937
|
$48,841,049 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
2.4%
|
3,104,103
|
$48,796,499 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.4%
|
3,094,611
|
$48,647,288 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,911,472
|
$45,774,621 | — | 31 Mar 2024 | |
| Douglas M. van Oort |
3/4/5
|
Director |
—
mixed-class rows
|
2,708,881
mixed-class rows
|
$45,677,027 | — | 01 Aug 2021 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,339,766
|
$36,781,121 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
2,317,458
|
$36,430,440 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.7%
|
2,197,551
|
$34,545,502 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
2,126,598
|
$33,430,125 | — | 31 Mar 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.5%
|
1,905,904
|
$29,960,811 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
1,813,208
|
$28,503,630 | — | 31 Mar 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
1.2%
|
1,557,895
|
$24,490,109 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,527,216
|
$24,007,835 | — | 31 Mar 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
1%
|
1,331,981
|
$20,938,741 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.96%
|
1,250,056
|
$19,650,881 | — | 31 Mar 2024 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.9%
|
1,164,992
|
$18,313,673 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.83%
|
1,077,817
|
$16,943,284 | — | 31 Mar 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.81%
|
1,051,627
|
$16,531,574 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.75%
|
979,371
|
$15,395,712 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
0.73%
|
946,025
|
$14,871,513 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.72%
|
937,852
|
$14,743,030 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.72%
|
931,617
|
$14,645,019 | — | 31 Mar 2024 | |
| Kopp Family Office, LLC |
13F
|
Company |
0.69%
|
894,509
|
$14,062,000 | — | 31 Mar 2024 | |
| LeRoy C. Kopp |
13F
|
Individual |
0.69%
|
894,509
|
$14,062,000 | — | 31 Mar 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.57%
|
737,200
|
$11,588,784 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.51%
|
662,059
|
$10,407,568 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.5%
|
645,492
|
$10,148,000 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.48%
|
620,271
|
$9,750,661 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.44%
|
574,897
|
$9,037,381 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.42%
|
540,581
|
$8,497,934 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
517,171
|
$8,129,928 | — | 31 Mar 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.36%
|
472,870
|
$7,433,516 | — | 31 Mar 2024 | |
| Mark Mallon |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
715,828
mixed-class rows
|
$6,768,458 | — | 01 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.32%
|
421,019
|
$6,618,419 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.3%
|
385,633
|
$6,062,122 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.29%
|
375,017
|
$5,895,267 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
356,686
|
$5,607,103 | — | 31 Mar 2024 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.25%
|
328,155
|
$5,158,596 | — | 31 Mar 2024 | |
| George Cardoza |
3/4/5
|
President & COO, Lab Ops |
—
mixed-class rows
|
304,659
mixed-class rows
|
$4,857,847 | — | 01 Mar 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.22%
|
280,621
|
$4,411,362 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.21%
|
267,760
|
$4,209,188 | — | 31 Mar 2024 |
Institutional Holders of NEOGENOMICS INC - Common Stock (NEO) as of Q2 2024
As of 30 Jun 2024,
NEOGENOMICS INC - Common Stock (NEO) was held by
253 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
125,764,461 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, BROWN ADVISORY INC, T. Rowe Price Investment Management, Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, Greenhouse Funds LLLP, SCHRODER INVESTMENT MANAGEMENT GROUP, First Light Asset Management, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
253
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
260
Q2 2024 holders
253
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.